Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. Dechra Pharmaceuticals PLC
  6. Summary
    DPH   GB0009633180

DECHRA PHARMACEUTICALS PLC

(DPH)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
09/13/2021 09/14/2021 09/15/2021 09/16/2021 09/17/2021 Date
4908(c) 4950(c) 4870(c) 4976(c) 5130(c) Last
267 489 285 866 138 228 184 445 1 430 634 Volume
-1.33% +0.86% -1.62% +2.18% +3.09% Change
More quotes
Estimated financial data (e)
Sales 2022 653 M 897 M 897 M
Net income 2022 65,5 M 90,0 M 90,0 M
Net Debt 2022 129 M 178 M 178 M
P/E ratio 2022 92,0x
Yield 2022 0,86%
Sales 2023 706 M 969 M 969 M
Net income 2023 80,5 M 111 M 111 M
Net Debt 2023 36,8 M 50,5 M 50,5 M
P/E ratio 2023 73,6x
Yield 2023 0,92%
Capitalization 5 552 M 7 636 M 7 627 M
EV / Sales 2022 8,70x
EV / Sales 2023 7,92x
Nbr of Employees -
Free-Float 98,4%
More Financials
Company
Dechra Pharmaceuticals PLC is engaged in veterinary pharmaceuticals and related products business. The Company is engaged in development, manufacture and marketing of products for veterinarians. Its segments include European Pharmaceuticals, North American (NA) Pharmaceuticals and Pharmaceuticals Research and Development. The European Pharmaceuticals Segment includes Dechra Veterinary Products Europe, Dechra... 
Sector
Pharmaceuticals
Calendar
10/21Shareholder meeting
More about the company
Ratings of Dechra Pharmaceuticals PLC
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about DECHRA PHARMACEUTICALS PLC
09/07DECHRA PHARMACEUTICALS : JP Morgan Raises Dechra Pharmaceuticals PT, Keeps Overw..
MT
09/07DECHRA PHARMACEUTICALS : Liberum Boosts Dechra's PT, Affirms Sell Rating
MT
09/06GLOBAL MARKETS LIVE : Puma, Boeing, Holcim, Revolut, Amazon...
09/06ANALYST RECOMMENDATIONS : Asos, Best Buy, Docusign, Greif, Hewlett Packard...
09/06DECHRA PHARMACEUTICALS : 06 September 2021 Preliminary Results Presentation for ..
PU
09/06FTSE 100 to Open Higher After Upbeat Asia Trading
DJ
09/06DECHRA PHARMACEUTICALS : Boosts Final Dividend Amid FY21 Profit Growth
MT
09/06DECHRA PHARMACEUTICALS : Earnings Flash (DPH.L) DECHRA PHARMACEUTICALS Reports F..
MT
09/06DECHRA PHARMACEUTICALS : Earnings Flash (DPH.L) DECHRA PHARMACEUTICALS Posts FY2..
MT
09/06Dechra Pharmaceuticals plc Reports Earnings Results for the Full Year Ended J..
CI
09/06Dechra Pharmaceuticals PLC Proposes Final Dividend, Payable on November 19, 2..
CI
08/25The latest from London: Morrisons to rally the FTSE 100
08/25Just Eat Takeaway.com to Lose Place in FTSE 100 Index in Latest Reshuffle
DJ
08/25FTSE : Morrisons set to enter FTSE 100 as M&A interest boost shares
RE
07/13DECHRA PHARMACEUTICALS : JPMorgan Lifts Dechra's PT, Affirms Overweight Rating
MT
More news
News in other languages on DECHRA PHARMACEUTICALS PLC
09/06MADRID STOCK EXCHANGE : ¿Qué hacemos ahora?
09/06STOCK MARKET PARIS : Qu'est-ce qu'on fait maintenant ?
09/06Dechra Pharmaceuticals augmente le dividende final en raison de la croissance..
09/06EN DIRECT DES MARCHES : TotalEnergies, Airbus, EDF, Spie, Holcim, J&J, Revolut....
09/06Earnings Flash (DPH.L) DECHRA PHARMACEUTICALS affiche un chiffre d'affaires d..
More news
Analyst Recommendations on DECHRA PHARMACEUTICALS PLC
More recommendations
Chart DECHRA PHARMACEUTICALS PLC
Duration : Period :
Dechra Pharmaceuticals PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DECHRA PHARMACEUTICALS PLC
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 9
Last Close Price 5 130,00 GBX
Average target price 4 914,44 GBX
Spread / Average Target -4,20%
EPS Revisions
Managers and Directors
Ian David Page Chief Executive Officer & Executive Director
Paul Sandland Chief Financial Officer & Executive Director
William Anthony Rice Non-Executive Chairman
Susan Longhofer Chief Scientific Officer
Allen Mellor Director-Information Technology
Sector and Competitors
1st jan.Capi. (M$)
DECHRA PHARMACEUTICALS PLC48.70%7 636
ZOETIS INC.19.93%94 073
ELANCO ANIMAL HEALTH INCORPORATED5.64%15 326
VIRBAC58.19%3 729
JINYU BIO-TECHNOLOGY CO., LTD.-26.62%2 652
SWEDENCARE AB (PUBL)137.54%2 099